61.82 0.00 (0.00%)
After hours: 4:36PM EDT
|Bid||54.00 x 100|
|Ask||93.00 x 100|
|Day's Range||61.40 - 62.18|
|52 Week Range||52.54 - 65.68|
|PE Ratio (TTM)||-18.04|
|Earnings Date||Nov 2, 2017 - Nov 6, 2017|
|Forward Dividend & Yield||0.35 (0.59%)|
|1y Target Est||66.64|
Nicholas Alexos Appointed EVP, Chief Administrative Officer Keith Ebling Appointed EVP, General Counsel & Secretary YORK, Pa., Oct. 16, 2017-- DENTSPLY SIRONA Inc., The Dental Solutions Company™, today ...
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing DENTSPLY SIRONA, Inc. with the following peers – Integra LifeSciences Holdings Corporation, Align Technology, Inc., BIOLASE, Inc., Danaher Corporation, 3M Company, Zimmer Biomet Holdings, Inc., Cantel Medical Corp. and Pro-Dex, Inc. (IART-US, ALGN-US, BIOL-US, DHR-US, MMM-US, ZBH-US, CMD-US and PDEX-US). DENTSPLY SIRONA, Inc.’s dividend yield ... Read more (Read more...)
DENTSPLY SIRONA's (XRAY) renewed distribution deal will aid the company to gain market traction. However, forex woes remain a concern.
This firm's move to bolster growth via a large acquisition recently resulted in the ouster of top executives. Despite pending new leadership, investors remain at risk given the firm's falling profits, lagging margins and overvalued stock price.
SAN DIEGO , Oct. 7, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by DENTSPLY SIRONA Inc. (NASDAQ: XRAY) ("Dentsply") ...
SAN FRANCISCO , Oct. 6, 2017 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors that it is investigating Dentsply Sirona, Inc. (NASDAQ: XRAY) for possible securities law violations. If you ...
Bragar Eagel & Squire, P.C. reminds investors that the firm is investigating potential claims against DENTSPLY SIRONA Inc. . Our investigation concerns whether Dentsply has violated the federal securities laws and/or engaged in other unlawful business practices.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Dentsply Sirona, Inc. violated federal securities laws.
Holzer & Holzer, LLC is investigating whether Dentsply Sirona, Inc. complied with the federal securities laws. On September 29, 2017, Dentsply reported more than a billion dollar loss for its second quarter, which was followed by the resignation of its top executive officers.
Directors of Dentsply Sirona forced out its chairman, CEO and president after a $14.5 billion merger completed last year ran into trouble, according to a person familiar with the matter.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to DENTSPLY SIRONA, Inc. Here are 5 ETFs with the largest exposure to XRAY-US. Comparing the performance and risk of DENTSPLY SIRONA, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for DENTSPLY SIRONA, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)
Law Offices of Howard G. Smith announces an investigation on behalf of Dentsply Sirona, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Dental-products and equipment maker Dentsply Sirona said its CEO, chief operating officer and executive chairman have all resigned. The changes come less than two months after the company said it is cooperating ...
Glancy Prongay & Murray LLP announces an investigation on behalf of Dentsply Sirona, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.
Shareholders of dental products maker Dentsply Sirona have heard it before and weren’t in a trusting mood Monday. The company’s shares plunged by as much as 8%. Dentsply's chief executive officer, chief ...
Dentsply Sirona Inc. announced Monday sweeping leadership changes, as Chief Executive Jeffrey Slovin, Executive Chairman Bret Wise and Chief Operating Officer Christopher Clark have all resigned. The dental ...
Mark A. Thierer Appointed Interim Chief Executive Officer Bob Size Appointed Interim President and Chief Operating Officer Company Reiterates Non-GAAP Adjusted EPS Guidance 1 for 2017 YORK, Pa., Oct. 02, ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
In August 2017, Dentsply Sirona (XRAY) launched its Cerec Zirconia Meso Block for creating customized screw-retained crowns.
Dentsply Sirona (XRAY) and Zephyr Sleep Technologies have entered into a strategic partnership for the treatment of OSA (obstructive sleep apnea).
According to the recommendations of 15 brokerage firms, 60.0% (or nine) of them have rated Dentsply Sirona (XRAY) a “buy,” and 33.0% (or five) have rated it a “hold.”
Open enrollment for healthcare begins in two weeks and people are already very confused. Consumers aren’t sure what kind of health care plans will be available or what the prices may be. Yahoo Finance’s Alexis Christoforous, Rick Newman and Justine Underhill explain why people are so confused.